Prolonged survival of a bare lymphocyte syndrome type I patient with diffuse panbronchiolitis treated with erythromycin [2]

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 18, Issue 3, 2001, Pages 312-313

  Azuma, A ^a   Keicho, N ^a   Furukawa, H ^a   Yabe, T ^a   Kudoh, S ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

BLS; Erythromycin; Respiratory functions

Indexed keywords

ERYTHROMYCIN; HEMAGGLUTININ; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA;

AIRWAY OBSTRUCTION; ANTIGEN PRESENTATION; BARE LYMPHOCYTE SYNDROME; BRONCHIOLITIS; DNA SEQUENCE; DRUG EFFICACY; GENE MUTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION TEST; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT INFECTION; SINUSITIS; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; BRONCHIOLITIS; ERYTHROMYCIN; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; SEVERE COMBINED IMMUNODEFICIENCY; SURVIVORS; TREATMENT OUTCOME;

EID: 0034828637     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Homozygous human TAP peptide transporter mutation in HLA class I deficiency
2. The bare-lymphocyte syndrome: Report on the registry
3. Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules
4. Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome
5. HLA class I deficiencies due to mutation in subunit 1 of the peptide transporter (TAP1)
6. Improvement of survival in patients with diffuse panbronchiolitis in Japan: Contribution of low-dose erythromycin treatment
7. Commentary: Immunodeficiency due to defective antigen processing: The molecular basis for type 1 bare lymphocyte syndrome
8. Long-term azythromycin may improve lung function in children with cystic fibrosis